GGrantIndex
Sort

64,565 grants matching drug discovery

Integrative Genetics and Genomics Core

$478,440
Vivek Philip · Jackson Laboratory · P50 · FY2022 · DA

Small Molecule Probes of the Neuropeptide S Receptor

$478,374
Scott P Runyon · Research Triangle Institute · R01 · FY2010 · MH

ERa is a novel RNA-binding protein controlling breast cancer

$478,371
Davide Ruggero · University Of California, San Francisco · R01 · FY2022 · CA

Computer Model of the Canine Ventricle

$478,351
Cornell University Ithaca · R01 · FY2005 · HL

A High-Repetition-Rate IR Laser for Mass Spectrometry

$478,349
Eli Margalith · Opotek, Inc. · R44 · FY2006 · RR

The Molecular Basis of Liquid-like Structure of the Nucleolus

$478,298
Richard W Kriwacki · St. Jude Children'S Research Hospital · R01 · FY2017 · GM

A GIP Companion Drug for Enhancing Metabolic Benefits of Long-Acting GLP-1

$478,280
Krishna Kumar · Velum, Inc. · R42 · FY2023 · AG

PLANT ANTI-HIV AGENTS

$478,235
Kuo-Hsiung Lee · Univ Of North Carolina Chapel Hill · R01 · FY2009 · AI

Chemistry Core

$478,235
Douglas E Frantz · Ut Southwestern Medical Center · P01 · FY2009 · CA

OST Inhibition in NSCLC

$478,219
Joseph N Contessa · Yale University · R01 · FY2022 · CA

OST Inhibition in NSCLC

$478,219
Joseph N Contessa · Yale University · R01 · FY2023 · CA

Development of Dopamine D3 Ligands as Medications for Psychostimulant Addiction

$478,187
Subramaniam Ananthan · Southern Research Institute · R01 · FY2009 · DA

Accelerating Site-specific Characterization of Protein Therapeutics with Novel Machine Learning Methods

$478,184
George Hall Johnson · Massmatrix, Inc. · R44 · FY2021 · GM

Identification of CYP5122A1 inhibitors as chemical probes for Leishmania biology

$478,164
Zhuo Michael Wang · University Of Kansas Lawrence · R01 · FY2021 · AI

Targeting Leptomeningeal Metastasis in Medulloblastoma

$478,163
Rachael W Sirianni · University Of Texas Hlth Sci Ctr Houston · R01 · FY2021 · NS

Impact of membrane composition on cholecystokinin receptor structure and function

$478,133
Laurence J Miller · Mayo Clinic Arizona · R01 · FY2022 · GM

NAD+ Pathway Signaling in Glioblastoma Tumor Growth and Therapy Resistance

$478,120
Albert Hong-Jae Kim · Washington University · R01 · FY2022 · NS

Metabolic Imaging of the Cardioprotective Effects of Alcohol and ALDH2 Activators

$478,120
Daniel M Spielman · Stanford University · R01 · FY2012 · AA

The Biology of Stem Cells in the Human Parasite Schistosoma Mansoni

$478,102
James J Collins · Ut Southwestern Medical Center · R01 · FY2022 · AI

Harmonic Acoustics for Neighboring cell Dynamic studies(HANDs)

$478,006
Luke P. Lee · Brigham And Women'S Hospital · R01 · FY2025 · GM

Broad spectrum antifungals targeting fatty acid biosynthesis

$477,999
Glen Palmer · University Of Tennessee Health Sci Ctr · R33 · FY2022 · AI

Preclinical validation of Kir4.1/5.1 inhibitors for overcoming diuretic resistance

$477,937
Jerod S Denton · Vanderbilt University Medical Center · R01 · FY2025 · DK

Annotating dark ion-channel functions using evolutionary features, machine learning and knowledge graph mining

$477,903
Natarajan Kannan · University Of Georgia · U01 · FY2022 · CA

Regulation of Inflammation and Lipid Homeostasis in Macrophage Foam Cells

$477,874
Christopher K Glass · University Of California, San Diego · P01 · FY2015 · HL

Towards a generalizable drug discovery framework based on intrinsically disordered regions

$477,873
Gil Alterovitz · Boston Children'S Hospital · R01 · FY2017 · GM